Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...

Comparatively, obesity rates in most European countries remain below 25 percent, with some nations, particularly in Southern ...

The researchers suggest that sleep deprivation may exacerbate the inflammatory state associated with obesity by increasing ...

Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up ...

It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...

The burden of obesity extends beyond its health effects. For example, a 2024 report estimated that obesity-related healthcare ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

Scientists have discovered new fat cell subpopulations with specialized functions, revealing differences between subcutaneous ...

Obesity extends far beyond carrying extra weight - it represents a chronic condition affecting millions globally. While ...

The findings of this study indicate that higher adherence to the Mediterranean diet is associated with a modest reduction in the risk of obesity-related cancers, independent of adiposity measures.

PM Modi's concern over India's rising obesity is justified, as data reveals a significant economic impact. The cost of ...